statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Asit C Mehta is bullish on Piramal Pharma has recommended buy rating on the stock with a target price of Rs 171 in its research report dated April 01 2024.

Buy Piramal Pharma; target of Rs 171: Asit C Mehta

Going ahead to the current week starting from April 1, close attention will be paid to the all-time high levels above 22,500, as hesitation was evident at these levels.

Hot Stocks: Here's why you should pick ICICI Pru Life and Piramal Pharma for short term

Piramal Pharma has negated lower highs formation seen in previous 11 consecutive sessions and saw gap up opening on Tuesday. The stock formed bullish candlestick pattern with long upper shadow on the daily charts.

Trade Spotlight | How you should deal in RHI Magnesita India, Rainbow Childrens Medicare, Piramal Pharma today

Motilal Oswal is bullish on Piramal Pharma recommended buy rating on the stock with a target price of Rs 165 in its research report dated January 31, 2024.

Buy Piramal Pharma; target of Rs 165: Motilal Oswal

Piramal Pharma Ltd. engages in development and manufacturing of pharmaceutical products. It offers skin care, vitamins and nutrition, antacids, analgesics, gastro-intestinal, and baby-care. The company was founded on March 4, 20202 and is headquartered in Mumbai, India.

Piramal Pharma Ltd.

Piramal Pharma Limited

Volume	26.69M
52-Wk High	153.90
52-Wk Low	70.80

PPLPHARMA.NSE Piramal Pharma Limited

About

Feed

News

Sentiment

Fundamentals

Sentiment

Message Volume

Community